Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |